Literature DB >> 10377208

Pulmonary lymphangioleiomyomatosis in Korea.

Y M Oh1, E K Mo, S H Jang, C G Yoo, Y W Kim, J W Seo, S K Han, J G Im, Y S Shim.   

Abstract

BACKGROUND: Pulmonary lymphangioleiomyomatosis (LAM) is a rare disease occurring in women of reproductive age and leading to progressive respiratory failure in spite of treatment. In Korea the first case was reported in 1984 and by 1997 a total of 23 cases had been reported. The clinical findings of these Korean cases are reviewed.
METHODS: The details of 10 cases of LAM on file at Seoul National University Hospital were reviewed together with those of 13 cases previously reported from other Korean institutes. Two, including the only one to be reported in a man, were excluded after reviewing the clinical, radiological, and pathological findings, leaving a total of 21 cases in the present study.
RESULTS: All 21 patients were women and in all cases the disease was proven pathologically. The mean (SD) age at onset of symptoms was 32 (8.6) years. The most common symptoms were dyspnoea and pneumothorax which were seen in 19 (90%) and 13 (76%) patients, respectively. Pulmonary function tests showed decreased transfer factor (TLCO) (100%) and airflow limitation (67%). All the cases had characteristic cysts on high resolution computed tomographic (HRCT) scanning. The overall severity score based on HRCT scans correlated with the percentage predicted TLCO/VA (p = 0.03) and FEV1/FVC (p = 0.02). The patients were all treated with medroxyprogesterone and/or tamoxifen. Follow up was possible in 10 cases. Two of these patients appeared to stabilise with no appreciable change clinically or in lung function on medroxyprogesterone and/or tamoxifen, but the remaining patients all deteriorated with two dying of respiratory insufficiency and one of infection following lung transplantation.
CONCLUSIONS: As in other countries, in Korea LAM occurs exclusively in women and progresses despite hormonal treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377208      PMCID: PMC1745515          DOI: 10.1136/thx.54.7.618

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  Lymphangioleiomyomatosis. Clinical course in 32 patients.

Authors:  J R Taylor; J Ryu; T V Colby; T A Raffin
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

2.  Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations.

Authors:  C B Carrington; D W Cugell; E A Gaensler; A Marks; R A Redding; J T Schaaf; A Tomasian
Journal:  Am Rev Respir Dis       Date:  1977-12

3.  Pulmonary lymphangiomyomatosis.

Authors:  E F Silverstein; K Ellis; M Wolff; A Jaretzki
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-04

4.  Pulmonary lymphangiomyoma, a probable forme frust of tuberous sclerosis. A case report and survey of the literature.

Authors:  Q J Valensi
Journal:  Am Rev Respir Dis       Date:  1973-12

5.  Lung transplantation for lymphangioleiomyomatosis.

Authors:  A Boehler; R Speich; E W Russi; W Weder
Journal:  N Engl J Med       Date:  1996-10-24       Impact factor: 91.245

6.  Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors.

Authors:  M Kitaichi; K Nishimura; H Itoh; T Izumi
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

7.  Pulmonary lymphangioleiomyomatosis in a male.

Authors:  H W Kang; C J Kim; S K Kang; K S Lee; C S Lee; Y H Kim
Journal:  J Korean Med Sci       Date:  1991-03       Impact factor: 2.153

  7 in total
  4 in total

Review 1.  Unusual causes of pneumothorax.

Authors:  Daniel R Ouellette; Scott Parrish; Robert F Browning; J Francis Turner; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.

Authors:  Hen Prizant; Aritro Sen; Allison Light; Sung-Nam Cho; Francesco J DeMayo; John P Lydon; Stephen R Hammes
Journal:  Mol Endocrinol       Date:  2013-07-02

3.  Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea.

Authors:  Shihwan Chang; Ji Soo Choi; Ah Young Leem; Su Hwan Lee; Sang Hoon Lee; Song Yee Kim; Kyung Soo Chung; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Jin Gu Lee; Hyo Chae Paik; Hyo Sup Shim; Eun Hye Lee; Moo Suk Park
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

4.  A nationwide survey of lymphangioleiomyomatosis in Korea: recent increase in newly diagnosed patients.

Authors:  Hye Yun Park; Hae-Seong Nam; Man Pyo Chung; Sung Hwan Jeong; Yu Jin Kim; Seung-Ick Cha; Young Whan Kim; Jong Sun Park; Soo-Taek Uh; Choon-Sik Park; Moo Suk Park; Ji Ae Moon; Kyung Soo Jung; Yang Jin Jegal; Dong Soon Kim; Jin Woo Song; Ho-Kee Yum; Young Bum Park
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.